HIV / AIDS in the News

Global AIDS Monitoring 2026 — Indicators and questions to monitor progress towards the Global AIDS Strategy 2026-2031 targets - ReliefWeb

 

AHF Sues FL Health Dept. to Block Emergency Rule Cutting HIV Drug Access for Thousands - Business Wire

 

Black LGBTQ+ leader derides Trump’s cuts to HIV funding after State of the Union - Advocate.com

 

AHF Sues FL Health Dept. to Block Emergency Rule Cutting HIV Drug Access for Thousands - AIDS Healthcare Foundation

 

Eye on Africa - Kenya administers HIV prevention drug - France 24

 

HIV progam rule challenge back in administrative court; attorneys conference in circuit court case - Florida Phoenix

 

$300K for HIV-positive seniors not included in SF budget ask - Bay Area Reporter

 

Nurse at Texas Jail Is Fired After Possibly Exposing Inmates to HIV - poz.com

 

Advocates warn cuts to HIV/AIDS drug assistance are a ‘death warrant’ for Floridians - WMNF

 

Bictegravir-Lenacapavir: Further Study Insights on the Investigative HIV Therapy - Contagion Live

 

Aging With HIV: Notes From the Long Haul - poz.com

 

[CROI 2026] MedPage Today: Age, HIV, and metabolic syndrome together tied to cognitive impairment risk - European AIDS Treatment Group

 

'Paradigm-shifting' study confirms effectiveness of long-acting HIV treatment - University of Cincinnati

 

President Trump: Save Florida’s AIDS Drug Assistance Program! - AIDS Healthcare Foundation

 

New HIV drug may end multi-pill regimen for older people - dw.com

 

CROI 2026: Meaningful Progress, Expanding Choice - avac.org

 

Positive 12-month data shows lotivibart maintains high levels of viral suppression in long-acting HIV treatment regimen - The Pharma Letter

 

Florida Department of Health cuts millions of dollars in funds from HIV and AIDS drug program - CBS News

 

Very Early ART Initiation in Children With HIV Could Lead to ART-Free Remission - MedPage Today

 

Injectable ART Suppressed HIV Long-Term in Teens - MedPage Today

 

Southern Nevada's Black community continues to face higher-than-average HIV rates - KNPR

 

[CROI 2026] Life4me+: Doravirine/islatravir for initial HIV therapy: A two-drug strategy in a three-drug world - European AIDS Treatment Group

 

GSK's ViiV confirms staying power of long-acting HIV treatment Cabenuva in adolescents - Fierce Pharma

 

Valley Healthcare to offer two opportunities for free HIV testing in March - WRBL

 

[CROI 2026] aidsmap: Bictegravir/lenacapavir combination pill could be an option for people taking complex regimens - European AIDS Treatment Group

 

Why is Florida ending longtime HIV drug assistance to more than 10,000? - The Palm Beach Post

 

Bictegravir/lenacapavir combination pill could be an option for people taking complex regimens - Aidsmap

 

[CROI 2026] [Press release] ViiV Healthcare reports positive 12-month data showing investigational bNAb lotivibart (N6LS) maintains high levels of viral suppression in long-acting HIV treatment regimen - European AIDS Treatment Group

 

[CROI 2026] [Press release] ViiV Healthcare presents pipeline data for two investigational HIV treatment therapies with potential for twice-yearly dosing - European AIDS Treatment Group

 

PrEP uptake was already low – and then came the cuts - Aidsmap